Luque-Tévar, M., Perez-Sanchez, C., Pilar, F. U., Romero-Gómez, M., Patiño-Trives, A. M., Ruiz, D., Arias de la Rosa, I., Abalos-Aguilera, M. D. C., Ortega Castro, R., Escudero Contreras, A., Rodríguez-Escalera, C., Pérez Venegas, J. J., Ruiz Montesinos, M. D., Dominguez, C., Romero Barco, C., Fernandez-Nebro, A., Mena-Vázquez, N., Marenco, J. L., Uceda, J., Toledo-Coello, M. D., Barbarroja Puerto, N., Aguirre, M. A., Lopez-Pedrera, C., & Collantes-Estévez, E. (n.d.). sAT0043 SERUM BIOMOLECULES AS POTENTIAL BIOMARKERS OF CLINICAL EFFICACY AND PREDICTORS OF RESPONSE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS. Annals of the rheumatic diseases, 79, 951–952. http://access.bl.uk/ark:/81055/vdc_100144724440.0x000043